Huons shifts to single-CEO leadership

Huons, a Korean pharmaceutical manufacturer, said Tuesday that it would transition to a single-CEO system under Song Soo-young following the resignation of Co-CEO Yoon Sang-bae.

Song has a background in management consulting. He previously served as CEO of Deloitte Korea (Deloitte Anjin) and Deloitte Japan (Deloitte Tohmatsu Group), global professional services firms specializing in consulting, audit, and financial advisory, and as senior vice president of PwC Japan.

At Huons, he was appointed as CEO of Huons Global in February 2022, recognized for his experience in management innovation and reform in global companies. In August 2023, he also became president of Huons Japan, leading the company’s expansion into the Japanese market.

Yoon, appointed as CEO in March 2022, previously held leadership positions at Boryung, Dong-A Pharmaceutical, and GSK Korea. His term was originally set to run until March 25, 2025.